Why Kadima is suing NRx Pharmaceuticals over the failed HOPE Therapeutics acquisition
The legal fight over Kadima Neuropsychiatry Institute tests NRx Pharmaceuticals’ acquisition discipline, financing credibility and evolving interventional psychiatry strategy.